Piers John Morgan

Piers John Morgan founded uniQure NV in 2009, where he worked as Chief Financial Officer from 2009 to 2014.
Mr. Morgan also currently works at European Biopharmaceutical Enterprises, as Vice Chairman-Innovation & Funding Models, Pathway Biotech Ltd., as Director, Ikarovec Ltd., as Non-Executive Director, and Institute of Chartered Accountants in England & Wales, as Member.
Mr. Morgan also formerly worked at C4X Discovery Ltd., as Chief Executive Officer & Director, C4X Discovery Holdings Plc, as Chief Executive Officer & Director from 2014 to 2015, Trino Therapeutics Ltd., as Non-Executive Chairman from 2012 to 2013, Pharnext SA, as Independent Non-Executive Director from 2021 to 2022, Quethera Ltd., as Non-Executive Director, Close Brothers Group Plc, as Principal, Phytopharm Plc, as Chief Financial Officer from 2007 to 2008, Arrow Therapeutics Ltd., as Chief Financial Officer, Valerio Therapeutics SA, as Chief Operating & Financial Officer from 2005 to 2012, Verona Pharma Plc, as Chief Financial Officer from 2016 to 2020, Amsterdam Molecular Therapeutics (AMT) Holding NV, as Chief Financial Officer & Vice President from 2012 to 2013, Compass Pathways Plc, as Chief Financial Officer, and Ernst & Young Corp.
Finance LLC.
Mr. Morgan received his graduate degree from the University of Cambridge.